These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32570166)

  • 1. A hypothesis about the role of fetal hemoglobin in COVID-19.
    Sotoudeh E; Sotoudeh H
    Med Hypotheses; 2020 Nov; 144():109994. PubMed ID: 32570166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic manipulation of fetal hemoglobin in the hemoglobinopathies.
    Nathan DG
    Ann N Y Acad Sci; 1990; 612():179-83. PubMed ID: 1705406
    [No Abstract]   [Full Text] [Related]  

  • 3. A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger.
    Mabaera R; West RJ; Conine SJ; Macari ER; Boyd CD; Engman CA; Lowrey CH
    Exp Hematol; 2008 Sep; 36(9):1057-72. PubMed ID: 18718415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies.
    Testa U
    Ann Hematol; 2009 Jun; 88(6):505-28. PubMed ID: 19011856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients.
    Stratopoulos A; Kolliopoulou A; Karamperis K; John A; Kydonopoulou K; Esftathiou G; Sgourou A; Kourakli A; Vlachaki E; Chalkia P; Theodoridou S; Papadakis MN; Gerou S; Symeonidis A; Katsila T; Ali BR; Papachatzopoulou A; Patrinos GP
    Pharmacogenomics; 2019 Jul; 20(11):791-801. PubMed ID: 31393228
    [No Abstract]   [Full Text] [Related]  

  • 6. Augmentation of hemoglobin synthesis by S-phase specific drugs in the K562 cell line.
    Dean A; Wu YJ; Ley T; Fordis CM; Schechter AN
    Prog Clin Biol Res; 1985; 191():205-16. PubMed ID: 2413473
    [No Abstract]   [Full Text] [Related]  

  • 7. Histone deacetylase inhibitor FK228 is a potent inducer of human fetal hemoglobin.
    Cao H; Stamatoyannopoulos G
    Am J Hematol; 2006 Dec; 81(12):981-3. PubMed ID: 16888791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic modulation of fetal globin gene expression in the perinatal period.
    Perrine SP
    Semin Perinatol; 1990 Oct; 14(5):346-50. PubMed ID: 1705052
    [No Abstract]   [Full Text] [Related]  

  • 9. The population dynamics of hemoglobins A, A
    Macharia AW; Uyoga S; Ndila C; Nyutu G; Makale J; Tendwa M; Nyatichi E; Ojal J; Atkinson S; Williams TN
    Haematologica; 2019 May; 104(5):e184-e186. PubMed ID: 30467202
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyurea therapy in highly unstable hemoglobin carriers.
    Rose C; Bauters F; Galacteros F
    Blood; 1996 Oct; 88(7):2807-8. PubMed ID: 8839880
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of hemoglobinopathies in north Jordan.
    Bashir N; Barkawi M; Sharif L; Momani A; Gharaibeh N
    Trop Geogr Med; 1992 Jan; 44(1-2):122-5. PubMed ID: 1379763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene structure in hereditary persistence of fetal hemoglobin individuals.
    Wilson LB; Huisman TH; Wilson JT
    Hemoglobin; 1980; 4(3-4):509-18. PubMed ID: 6158504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
    Fathallah H; Atweh GF
    Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on fetal hemoglobin gene regulation in hemoglobinopathies.
    Bauer DE; Orkin SH
    Curr Opin Pediatr; 2011 Feb; 23(1):1-8. PubMed ID: 21157349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2.
    Rodriguez-Capote K; Higgins TN
    Clin Biochem; 2015 Jul; 48(10-11):698-702. PubMed ID: 25869492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. delta beta-Thalassemia and HPFH.
    Ottolenghi S; Giglioni B; Taramelli R; Comi P; Gianni AM
    Birth Defects Orig Artic Ser; 1982; 18(7):65-7. PubMed ID: 6186314
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic persistence of fetal hemoglobin.
    Little JA; Dempsey NJ; Tuchman M; Ginder GD
    Blood; 1995 Apr; 85(7):1712-8. PubMed ID: 7535584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Protein Degradation as a Promising Tool for Epigenetic Upregulation of Fetal Hemoglobin.
    J Verheul TC; Trinh VT; Vázquez O; Philipsen S
    ChemMedChem; 2020 Dec; 15(24):2436-2443. PubMed ID: 33002296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple physical stresses induce γ-globin gene expression and fetal hemoglobin production in erythroid cells.
    Schaeffer EK; West RJ; Conine SJ; Lowrey CH
    Blood Cells Mol Dis; 2014 Apr; 52(4):214-24. PubMed ID: 24314748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
    Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP
    Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.